Here to help — Zolid AI can answer questions and provide insights. Free for now, with fair usage limits.
Your conversations are not shared with others. We may review them to improve Zolid AI.
Zolid AI may provide inaccurate info, so verify responses.
Galectin Therapeutics, Inc. (NASDAQ: GALT) is the leading developer of compounds that target galectin proteins to treat fibrosis and cancer. Building upon positive preclinical studies in animals, the company’s primary focus is on NASH (non-alcoholic steatohepatitis) with advanced fibrosis and…
Finance: Commercial Banking, Lending, Underwriting
No mentions listed yet.
No one has curated this page yet. Be the first.
Curate